BRKR
$33.74
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions.
Recent News
Assessing Bruker (BRKR) Valuation After Steep Multi‑Period Share Price Declines
Bruker Stock Snapshot After Recent Performance Bruker (BRKR) has drawn fresh attention after a stretch of weaker share performance, including a return of about a 30% decline over the past year and a 54% decline over the past 3 months. See our latest analysis for Bruker. Recent trading reflects fading momentum, with a 7 day share price return showing a 7.81% decline and a 90 day share price return showing a 24.03% decline, while the 5 year total shareholder return of a 44.07% loss signals...
Will Bruker (BRKR) be Able to Rebound?
Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Small Cap Fund”. A copy of the letter can be downloaded here. The Fund seeks to invest in companies that possess franchise characteristics, with strong earnings trajectories, and are trading at a discount to the estimated private market value. Despite strong results […]
Bio-Techne, Bruker, DexCom, STERIS, and Teleflex Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the healthcare industry showing significant job losses.
Research Tools & Consumables Stocks Q4 In Review: Bruker (NASDAQ:BRKR) Vs Peers
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Bruker (NASDAQ:BRKR) and the rest of the research tools & consumables stocks fared in Q4.
Bruker (BRKR): Buy, Sell, or Hold Post Q4 Earnings?
Over the past six months, Bruker has been a great trade, beating the S&P 500 by 16%. Its stock price has climbed to $41.37, representing a healthy 23.2% increase. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.